Kyogoku unyu shoji
9073
BlueMeme
4069
Estore
4304
Visumo
303A
D. Western Therapeutics Institute
4576
(FY)Dec 31, 2023 | (FY)Dec 31, 2022 | (FY)Dec 31, 2021 | (FY)Dec 31, 2020 | (FY)Dec 31, 2019 | (FY)Dec 31, 2018 | (FY)Dec 31, 2017 | (FY)Dec 31, 2016 | (FY)Dec 31, 2015 | |
---|---|---|---|---|---|---|---|---|---|
Operating cash flow (Indirect Method) | |||||||||
Cash from operating activities | -7.37%625.84M | -12.25%675.6M | 31.36%769.89M | 344.85%586.08M | -59.85%131.75M | 58.45%328.13M | 51.36%207.09M | 43.34%136.82M | 95.45M |
Net profit before non-cash adjustment | -20.96%391.53M | -10.35%495.35M | 0.67%552.55M | 744.96%548.87M | -66.38%64.96M | 78.17%193.19M | 32.22%108.43M | 97.04%82M | --41.62M |
Total adjustment of non-cash items | 17.33%244.76M | 47.20%208.62M | 13.21%141.73M | 34.82%125.19M | -38.85%92.86M | 65.86%151.85M | 50.92%91.55M | -3.08%60.66M | --62.59M |
-Depreciation and amortization | 31.67%241.93M | 33.44%183.74M | 30.52%137.69M | 14.03%105.49M | -4.30%92.51M | 17.94%96.67M | 36.31%81.96M | 42.99%60.13M | --42.05M |
-Reversal of impairment losses recognized in profit and loss | --1.22M | --0 | ---- | ---- | ---- | --30.81M | ---- | ---- | ---- |
-Assets reserve and write-off | ---- | ---- | ---- | ---- | ---- | ---- | ---- | 107.95%92K | ---1.16M |
-Disposal profit | --0 | --5.69M | --0 | --0 | --805K | --0 | --0 | --0 | --20.64M |
-Net exchange gains and losses | -278.95%-306K | -5.00%171K | -55.00%180K | 246.52%400K | -953.13%-273K | -91.53%32K | 502.13%378K | ---94K | ---- |
-Other non-cash items | -89.96%1.91M | 393.15%19.02M | -80.02%3.86M | 10,589.67%19.3M | -100.76%-184K | 164.27%24.34M | 1,627.77%9.21M | -49.33%533K | --1.05M |
Changes in working capital | 63.12%-10.46M | -137.51%-28.37M | 185.95%75.62M | -237.54%-87.98M | -54.19%-26.07M | -337.76%-16.91M | 221.50%7.11M | 33.19%-5.85M | ---8.76M |
-Change in receivables | -35.62%-34.89M | -175.94%-25.72M | 114.75%33.87M | -966.66%-229.72M | -6.50%-21.54M | 19.57%-20.22M | -22.83%-25.14M | -122.46%-20.47M | ---9.2M |
-Change in inventory | -142.22%-3.6M | 305.10%8.52M | ---4.16M | --0 | ---- | ---- | ---- | ---- | ---- |
-Change in prepaid assets | 136.89%2.87M | -13.59%-7.77M | 5.09%-6.84M | -222.17%-7.21M | 286.15%5.9M | -168.19%-3.17M | 74.54%-1.18M | -446.49%-4.64M | --1.34M |
-Change in payables | -585.82%-17.21M | 91.44%-2.51M | -125.38%-29.33M | 808.83%115.58M | -812.42%-16.31M | -109.77%-1.79M | 891.81%18.29M | 12.37%1.84M | --1.64M |
-Change in accrued expense | 43.99%5.12M | -12.36%3.55M | 25.74%4.05M | 121.28%3.22M | -19.68%1.46M | 150.55%1.81M | -94.74%724K | 280.69%13.77M | ---7.62M |
-Provision for loans, leases and other losses | 77.37%6.41M | -43.65%3.61M | -65.64%6.41M | 529.82%18.67M | -79.39%-4.34M | -149.40%-2.42M | --4.9M | ---- | ---- |
-Changes in other current assets | 483.13%30.85M | -111.24%-8.05M | 523.95%71.6M | 31.00%11.48M | -1.36%8.76M | -6.71%8.88M | 160.75%9.52M | -28.12%3.65M | --5.08M |
Dividends paid (cash flow from operating activities) | |||||||||
Dividends received (cash flow from operating activities) | |||||||||
Interest paid (cash flow from operating activities) | 82.00%-90K | -500K | 99.00%-1K | 81.38%-100K | 49.58%-537K | -1.07M | |||
Interest received (cash flow from operating activities) | -5.88%16K | 54.55%17K | 0.00%11K | -66.67%11K | 266.67%33K | 80.00%9K | -72.22%5K | -52.63%18K | 38K |
Tax refund paid | -13.27%-150.22M | 50.37%-132.62M | -1,974.21%-267.23M | 117.58%14.26M | -123.42%-81.08M | 10.23%-36.29M | -157.11%-40.43M | -25.25%-15.72M | -12.55M |
Other operating cash inflow (outflow) | 0 | -1K | 0 | 0.00%1K | 200.00%1K | 0.00%-1K | -200.00%-1K | 100.02%1K | -6.35M |
Operating cash flow | -12.34%475.54M | 7.92%542.5M | -16.27%502.68M | 1,084.13%600.35M | -82.63%50.7M | 75.21%291.85M | 38.15%166.57M | 59.67%120.57M | --75.52M |
Investing cash flow | |||||||||
Net PPE purchase and sale | 99.25%-244K | ---32.52M | ---- | ---- | ---8.36M | ---- | 65.03%-171K | ---489K | ---- |
Net intangibles purchase and sale | -26.55%-426.55M | -52.63%-337.06M | -17.94%-220.83M | -52.88%-187.24M | -10.98%-122.48M | 2.53%-110.36M | -22.11%-113.23M | 36.32%-92.72M | ---145.61M |
Net business purchase and sale | --0 | ---89.83M | ---- | ---- | ---- | ---- | ---- | ---- | ---- |
Net changes in other investments | 84.12%-7.04M | -2,065.69%-44.31M | -3,367.80%-2.05M | ---59K | ---- | -2,777.04%-13.41M | -2,688.89%-466K | --18K | ---- |
Investing cash flow | 13.87%-433.83M | -126.01%-503.71M | -19.00%-222.88M | -43.16%-187.3M | -5.71%-130.83M | -8.70%-123.77M | -22.18%-113.86M | 36.00%-93.2M | ---145.61M |
Financing cash flow | |||||||||
Net issuance payments of debt | -210.99%-106M | --95.5M | ---- | ---- | ---- | ---- | 27.97%-26.41M | 0.00%-36.66M | ---36.66M |
Net common stock issuance | ---114.51M | --0 | 62.34%11.76M | 7,889.25%7.24M | -101.16%-93K | -96.98%8M | --265.36M | ---- | ---- |
Net other fund-raising expenses | ---- | ---45.39M | ---- | ---1K | ---- | -100.02%-1K | --4.34M | ---- | ---- |
Financing cash flow | -540.06%-220.51M | 326.11%50.11M | 62.36%11.76M | 7,888.17%7.24M | -101.16%-93K | -96.71%8M | 763.64%243.29M | 0.00%-36.66M | ---36.66M |
Net cash flow | |||||||||
Beginning cash position | 7.13%1.33B | 30.57%1.24B | 78.75%953.13M | -13.04%533.23M | 40.32%613.18M | 209.92%437M | -6.18%141M | -41.53%150.29M | --257.04M |
Current changes in cash | -301.13%-178.8M | -69.51%88.9M | -30.63%291.56M | 623.90%420.3M | -145.56%-80.23M | -40.51%176.08M | 3,289.25%295.99M | 91.31%-9.28M | ---106.75M |
Effect of exchange rate changes | 278.95%306K | 5.00%-171K | 55.00%-180K | -246.52%-400K | 165.05%273K | --103K | ---- | ---- | ---- |
Cash adjustments other than cash changes | ---1K | ---- | ---- | ---- | -200.00%-1K | 0.00%1K | 200.00%1K | ---1K | ---- |
End cash Position | -13.39%1.15B | 7.13%1.33B | 30.57%1.24B | 78.75%953.13M | -13.04%533.23M | 40.32%613.18M | 209.92%437M | -6.18%141M | --150.29M |
Free cash flow | -71.81%48.75M | -38.65%172.93M | -31.78%281.85M | 615.55%413.12M | -144.15%-80.13M | 241.33%181.49M | 94.33%53.17M | 139.04%27.36M | ---70.09M |
Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |